Third Harmonic Bio Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
THRD Nasdaq 2836 https://thirdharmonicbio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Third Harmonic Bio Inc

Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results - Mar 29th, 2023 12:05 pm
The Petri Dish: Third Harmonic axes lead program; bluebird moves forward with 3rd drug - Dec 22nd, 2022 10:41 am
Third Harmonic Bio Stock Plummets After Trial Discontinuation On Safety Concerns - Dec 15th, 2022 3:10 pm
We Think Third Harmonic Bio (NASDAQ:THRD) Can Afford To Drive Business Growth - Dec 15th, 2022 1:49 pm
Third Harmonic Bio Announces Discontinuation of Phase 1b Study of THB001 in Chronic Inducible Urticaria - Dec 15th, 2022 12:00 pm
Third Harmonic Bio to Participate in Fireside Chat at the Evercore ISI 5th Annual HealthCONx Conference - Nov 21st, 2022 9:05 pm
Third Harmonic Bio Announces Third Quarter 2022 Financial Results and Provides Corporate Update - Nov 9th, 2022 9:15 pm
These Bases, Breakouts And Buy Zones Offer Fresh Opportunities - Nov 2nd, 2022 12:01 pm
Third Harmonic Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares - Sep 19th, 2022 8:10 pm